Related by context. All words. (Click for frequent words.) 80 Michele Garufi Chairman 69 Barry D. Quart 69 ThromboGenics commenting 68 Patrik De Haes 67 Juergen Engel Ph.D. 66 Ron Bentsur 66 Dr. Fahar Merchant 66 Ph.D. Targacept 66 Dr. Arndt Schottelius 65 Daniel Junius 65 Per Olof Wallström 65 Michael H. Tardugno 65 Vincent Mutel CEO 65 Dr. Bassam Damaj 65 Mark A. Sirgo 65 PharmD Ardea 65 Georges Gemayel 65 Mr. Rosconi 64 Dr. Philip Toleikis 64 CCR9 antagonist 64 Steve Worland Ph.D. 64 Ablynx commented 64 Mr. Yves Rosconi 64 EnzymeRx 64 Anthony Giovinazzo 64 J. Mazzo Ph.D. 63 ANAVEX 63 Marc Oczachowski 63 Kiadis Pharma 63 Peter Riehl Stellar 63 Spiro Rombotis President 63 Tod Woolf Ph.D. 63 Keith Katkin AVANIR 63 Ulrich Dauer CEO 63 Mr. Jassawalla 63 Mr. Bentsur 62 INT# [002] 62 Neil K. Warma 62 Michael V. Novinski 62 Elisabeth Lindner CEO 62 Mr. Luc Mainville 62 Steven B. Ratoff 62 preclinically 62 Greg Wujek 62 Mihael Polymeropoulos MD 62 Dr. Isa Odidi 62 Adrian Hobden Ph.D. 62 Shai N. Gozani 62 Paolo Paoletti MD 62 Preclinical Development 62 Kleanthis G. Xanthopoulos Ph.D. 62 Hoyoung Huh MD Ph.D. 62 Hugues de Bantel 62 Christoph Westphal MD Ph.D. 62 4SC commented 62 Cerimon Pharmaceuticals Inc. 62 Errol De Souza 62 Carl A. Pelzel 62 CR# vcMMAE 61 Mitchel Sayare 61 Safi Bahcall Ph.D. 61 Kees Been 61 Zosano 61 André Michel Ballester 61 David Aviezer 61 Can Fite 61 Dr. Wolfgang Wein 61 Arpida Ltd. 61 Dr. Marlies Sproll 61 Mr. Zhiyuan Li 61 James Manuso 61 Svein Mathisen CEO 61 Anthony DiTonno President 61 Manja Bouman CEO 61 Ed Quilty 61 Æterna Zentaris 61 Dr. Henrich Guntermann 61 Pedro Lichtinger 61 James Sapirstein 61 Oncology Merck Serono 61 Dr. Randall Yatscoff 61 Mr. Kriegsman 61 Hoyoung Huh 61 Steven A. Kriegsman 61 XTLbio 61 Brian JG Pereira 61 Robert L. Chioini 61 Kirsten Drejer 61 Fred Duffner 60 Michel Morre DVM 60 stated Belinda Tsao 60 Loic Maurel 60 Alton Boynton 60 OMNARIS HFA 60 eprotirome 60 Jeffrey M. Ostrove 60 Christian Itin 60 Dr. Steven Tsengas 60 oral picoplatin 60 Dan Passeri 60 Dr. Aiping Young 60 Antenor Silva President 60 Dr. Stylli 60 Paul Laikind 60 Dr. Wayne Danter 60 ThromboGenics commented 60 Damian Marron 60 Mr. Frank Menzler 60 Arginox 60 J. Donald deBethizy 60 David H. Fater 60 Yves Rosconi President 60 Steve Cartt Executive 60 Impax Pharmaceuticals 60 Oracea TM 60 Howard H. Pien 60 Mark Leuchtenberger 60 Fran DiNuzzo 60 Murray Tekmira 60 Avtar Dhillon MD 60 Simon Sturge 60 Neogenix 60 Ralph Makar 60 Harry Palmin President 60 TRO# 60 Elafin 60 Dan Passeri Curis 60 IMA# 60 Prof. Desire Collen 60 Patrick Fourteau 60 InteKrin 60 Tom van Aken 60 PhytoMedical Technologies Inc. 60 Ostabolin C 60 huC# DM4 60 Agile Therapeutics 60 Iris Loew Friedrich 59 Deborah Dunsire MD 59 R#/MEM # 59 Uli Hacksell Ph.D. 59 Lonnie Moulder 59 Alvine Pharmaceuticals 59 alvespimycin 59 Nicole Onetto MD 59 Hem Pandya 59 Zami Aberman Chairman 59 Mr. Weidong Yin 59 Mr. Armando Anido 59 Dr. Yatscoff 59 Dino Dina 59 Loïc Maurel MD 59 Glen de Vries 59 Rolland Yves Mauvernay 59 Elocalcitol 59 Jeff Morhet Chairman 59 Rob Cascella President 59 Kathleen Danenberg 59 Sernova 59 Juergen Engel 59 Pascal Pfister 59 PRTX 59 Personalized Immunotherapy 59 Dr. Pingpank 59 Daniel O. Wilds 59 Solarfun commented 59 anticoagulant reversing agent 59 Wolfgang Renner 59 Gilles Gagnon 59 Brad Bolzon 59 ERYtech Pharma 59 ThGRF 59 Jim Musick Vitro 59 Vaughn M. Kailian 59 Vojo Vukovic MD Ph.D. 59 Onno van de Stolpe 59 Jal S. Jassawalla 59 Loretta M. Itri 59 Dr. Declan Doogan 59 forodesine 59 Dr. Gussak 59 Alfred Sandrock MD Ph.D. 59 Michele Garufi 59 Zami Aberman Pluristem 59 Bruce Galton 59 LibiGel ® 59 GLYX 59 Mark Pykett 59 David Schenkein MD 59 Yves Rosconi 59 Kemal Malik 59 Friedhelm Blobel Ph.D. 59 TOCOSOL Paclitaxel 59 immatics 59 Lung Rx 59 Mark Leuchtenberger President 58 Mr. Mordock 58 Robert L. Bratzler 58 PHX# 58 Emer Leahy 58 Cempra 58 Trophos 58 Dr. Hassan Salari 58 SILENOR 58 ganetespib 58 Joanna Horobin MD 58 oral salmon calcitonin 58 Daniel H. Movens 58 leading oral taxane 58 Daniel Vasella Chairman 58 Pervasis 58 Paolo Paoletti 58 EDAP TMS 58 Dr. Hombeck 58 Amir Avniel 58 CTAP# Capsules 58 SCOLR Pharma 58 Jim Sulat 58 Kevin Rakin 58 obatoclax 58 compound INCB# 58 cMET 58 Dr. Karl Mettinger 58 oral ridaforolimus 58 Daniel Tasse 58 Francois Nader 58 Dr. Seizinger 58 Dr Mario Polywka 58 Armando Anido Chief Executive 58 pexiganan 58 Jan Egberts 58 commented Nicholas Landekic 58 Dr. Masamichi Koike 58 Jean Stéphenne 58 phase IIa clinical 58 Dr. Blobel 58 Frank Morich 58 Chang Ahn Rexahn 58 Antony Koblish President 58 Arthur S. Przybyl 58 JP-#/fipamezole 58 deforolimus 58 CEO Peter Dornau 58 FOLOTYN ® 58 MEK inhibitor RDEA# 58 Sanjay Bhanot 58 Sylvie Gregoire 58 Ph.D. XenoPort 58 MAA submission 58 Geoffrey Kempler 58 Bicifadine 58 Ira L. Goldknopf 58 Aegerion 58 MD Ph.D. NeuroMetrix 58 Bernd R. Seizinger 58 Dr. Cauwenbergh 58 ABMC Chief Executive 58 GRN# 58 PregLem 58 Martin Nicklasson 58 Telatinib 58 Dominique Costantini 58 CRLX# 58 Phase IIb trials 58 SNT MC# 58 Cerenis 58 Randy Lubinsky 57 ProtoKinetix 57 Arno Therapeutics 57 Lorianne Masuoka MD 57 Donald L. Drakeman 57 nalbuphine ER 57 Dr. Michelle Berrey 57 ZOLINZA 57 Revotar 57 tanespimycin 57 Howard Fillit MD 57 PROCHYMAL 57 Eran Broshy 57 OHR/AVR# 57 Archexin 57 Cynapsus formerly 57 Dr. Kobi Vortman 57 GFT# 57 Andy Boorn 57 TYSABRI natalizumab 57 Regado Biosciences 57 Hakan Edstrom 57 CRMD# 57 Anna Gluskin 57 Roger Boissonneault 57 RLY# 57 PsychoGenics 57 ImmunoCellular Therapeutics 57 EnVivo 57 Sirona Biochem 57 REGENERX BIOPHARMACEUTICALS INC. 57 Philippe Giaro President 57 Tony Bihl 57 Ms. Zhilin Li 57 Novosom 57 Dr. Damaj 57 Mark HN Corrigan 57 Phase 1b trial 57 CRD5 57 Blum Cytokinetics 57 Taligen 57 Phase #b/#a clinical 57 Jacob Inbar 57 subsidiaries visit http:/www.apricusbio.com 57 QTinno TM 57 Gregory D. Casciaro 57 commented Mitchel Sayare 57 SITRONICS commented 57 Mark Sirgo 57 Phase III ADT 57 Officer Stan Cipkowski 57 Enobia 57 ATL/TV# 57 JenaValve 57 Pyng Medical 57 epigenetic therapies 57 Sijmen de Vries 57 Creabilis Therapeutics 57 Frank Verwiel MD 57 Virulizin ® 57 Jinpan commented 57 HuMax EGFr 57 Michael Kishbauch 57 TEMSO 57 Civacir 57 Dr. Horst Zerbe 57 AZILECT ® 57 David Bupp Neoprobe 57 Initiates Enrollment 57 Viprinex TM 57 Jean Luc Belingard 57 Gerd Zettlmeissl CEO 57 Marc de Garidel 57 octreotide implant 57 Gerard E. Puorro 57 tiapamil 57 MERLIN TIMI 57 John Maraganore Ph.D. 57 Speedel Holding Ltd 57 Zingo TM 57 Numoda 57 Nasdaq INCY 57 BioRexis 57 Drew Fromkin President 57 TKM ApoB 57 Joshua Boger Ph.D. 57 Stuart Essig Integra 57 Morten Jurs 57 Novartis Molecular Diagnostics 57 OTCBB CVBT 57 ponatinib 57 MD Halozyme 57 Igor Gonda 57 talactoferrin 57 Pascal Delmas 57 Cytheris 57 Aviptadil 57 trodusquemine 57 lomitapide 57 Vincent Milano ViroPharma 57 Yaffa Beck 57 David Pernock 57 liprotamase 57 Tikvah Therapeutics 57 Tom Giannopoulos MICROS 57 glucokinase activator 57 ProSavin 57 Ofer Haviv Evogene 57 Kathy Heptinstall Operating 57 Zavesca r 57 NASDAQ IPXL today 57 NEBIDO 57 commented Alexis Borisy 57 Sudhir Agrawal D.Phil 57 FRANKFURT MEH 57 Andrew Uprichard 57 Cytochroma 56 Dr. Sosne 56 ProFibrix 56 Ulrich Grau Ph.D. 56 enzastaurin 56 Sinobiopharma 56 Nancy Simonian MD 56 Mary Tagliaferri 56 Daniel Von Hoff 56 DDP# 56 Cascade LifeSciences 56 TOPIGEN 56 Yuval Cohen 56 MD FACS FAAP 56 Thomas Sandgaard CEO 56 Dr. Flemming Ornskov 56 Gunther Braun 56 NP2 Enkephalin 56 Branislav Vajdic Ph.D. 56 vidofludimus 56 Bernd Seizinger 56 Torbjörn Bjerke 56 DSM Biomedical 56 Anat Cohen Dayag 56 Daniel Passeri Curis 56 Scott Pancoast Lpath 56 IRX 2 56 MacuSight 56 IND submission 56 atacicept 56 ulimorelin 56 Cerus Corporation 56 Proteo 56 Jean Luc Bélingard Chairman 56 axitinib 56 Chemokine Therapeutics 56 Anders Gersel Pedersen 56 Sheldon Berkle 56 Aegera 56 HQK 56 brivaracetam 56 Evoltra ® 56 cannabinor 56 ImaginAb 56 phase IIb trial 56 Tapestry Pharmaceuticals 56 Prabhavathi Fernandes Ph.D. 56 HGS# 56 John F. Thero 56 Steven Kriegsman 56 Axentis Pharma 56 Pedro Lichtinger Optimer 56 Alexis V. Lukianov 56 Santhera 56 SNT-MC#/idebenone 56 Tony Milici 56 ESBATech 56 Masafumi Nogimori 56 faropenem 56 DPX Survivac 56 aEURoeWe 56 romazarit 56 Frank Condella 56 Phase Ib study 56 Gord Froehlich President 56 Dr. Bruno Giannetti 56 Alexis Borisy President 56 Ceflatonin 56 4SC AG 56 Tracleer r 56 Torbjorn Bjerke 56 Insegia 56 ThromboGenics 56 Ceragenix 56 Charlotte Keywood 56 Phenoptin 56 Eric von Hofe 56 David Sidransky 56 Chemophase 56 Igeneon 56 Matthias L. Wolfgruber 56 radezolid 56 PXD# 56 Christopher Corsico MD MPH 56 JAK inhibitors 56 Dr. Bernhard Kirschbaum 56 ENZON 56 GSK '# 56 GSK Biologicals 56 Christopher Anzalone Arrowhead 56 Anders Lonner 56 Duane DeSisto 56 Orville G. Kolterman 56 Rezular 56 Matthew Emmens 56 Per Olof Andersson 56 EKR Therapeutics 56 Adrian Hobden 56 Remi Barbier 56 torezolid phosphate 56 Dr Werner Lanthaler 56 Mr. Fater 56 Sinobiomed 56 Kathy Giusti Founder 56 AltheaDx 56 Geoffrey Kempler Prana 56 James DeOlden 56 Ray Salemme 56 Jeffrey H. Buchalter 56 Relovair 56 Spiegelmer ® 55 therapeutic monoclonal antibody 55 Dr. Raafat Fahim 55 Cerimon Pharmaceuticals 55 HuLuc# 55 Xcytrin R 55 ONCONASE R 55 Critchfield MD 55 Carl LeBel 55 MAGE A3 ASCI 55 APEX PD 55 oral FTY# 55 Dr. Francesco Bellini 55 CardioVascular BioTherapeutics Inc. 55 Fibrillex TM 55 Christopher J. Schaber 55 Loramyc 55 Edward Smolyansky CFO 55 Syndax 55 OMRIX Biopharmaceuticals Inc. 55 Philippe Calais 55 DCCR 55 elotuzumab 55 NOXXON 55 SMT C# 55 KIACTA ™ 55 Alex Lukianov Chairman 55 Theodore Zucconi Ph.D. 55 zanolimumab 55 tubulin inhibitor 55 AEterna Zentaris 55 Keith Katkin 55 Ronan O'Caoimh CEO 55 Emisphere Technologies 55 von Rickenbach 55 Alan Kessman Chief Executive 55 Chain Intellect 55 DMD DMSc 55 Philippe Archinard 55 Bruno Tocque 55 tezampanel 55 rALLy clinical trial 55 Addrenex 55 arGEN X 55 K. Wotton Ph.D. 55 Cethromycin 55 Phase 2a trial 55 RHEI Pharmaceuticals 55 Stephane Bancel 55 Cinryze ™ 55 AMEX RGN 55 Ronald Brus 55 Sol J. Barer 55 Harold Van Wart 55 Peter A. Lankau 55 ularitide 55 riociguat 55 Initiates Clinical 55 Completes Patient Enrollment 55 eritoran 55 Mr. Zami Aberman 55 Dr. Guoqing Jiang 55 MyVax ® 55 romidepsin 55 BGC# 55 SANCTURA XR NEBIDO 55 Jean Luc Bélingard 55 Eckard Weber 55 Initiates Phase II 55 Jack Lief Arena 55 NASDAQ AVEO 55 oral PTH 55 Aflibercept 55 Steven R. Deitcher 55 Regulus Therapeutics 55 TSX VENTURE SVA 55 Marc Cluzel 55 Jay Flatley Illumina 55 Symadex 55 Charles Homcy MD 55 successfully commercialize Iluvien 55 EDEMA3 trial 55 Opexa 55 Surfaxin LS 55 Dynogen 55 Kuslima Shogen 55 Doug Engfer 55 Bernie Landes 55 Dr. Rahul Singhvi 55 BLA filing 55 Euroscreen 55 John R. Plachetka 55 Icatibant 55 VentiRx 55 Mr. Zwi Williger 55 Apricus Biosciences 55 Rosen ViroPharma 55 Intendis 55 CaPre TM 55 BioNumerik 55 SUCCEED trial 55 GammaCan 55 Dr. Dov Tamarkin 55 Werner Cautreels 55 QRxPharma 55 Timo Veromaa 55 June Almenoff MD 55 Tuan Ha Ngoc 55 CINQUIL 55 stated Dominique Costantini 55 Omthera 55 ADVANCE PD 55 Orexo 55 Dr. Rietiker 55 molecular imaging radiopharmaceutical 55 Anker MD Ph.D. 55 severe hypercholesterolemia 55 OTCBB PYTO 55 Ocrelizumab 55 Pimavanserin 55 Anders Hedegaard President 55 Paladin Labs 55 Carl Spana Ph.D. 55 PNT# 55 Newron 55 Prabhavathi Fernandes 55 Al Altomari 55 Resverlogix Corp. Resverlogix 55 CEO Farhad Moghadam 55 ORTHOCON 55 Lixivaptan 55 Nanobiotix 55 Theratechnologies 55 Genaera Corporation 55 Prestara 55 Valturna 55 Metaphore 55 QuatRx 55 Genz # 55 Excaliard 55 Carlo Montagner 55 Ivan Gergel MD 55 FluoroPharma 55 William H. Rastetter 55 Photocure 55 Professor Silviu Itescu 55 JAK inhibitor 55 Clay B. Siegall 55 Dr Bernd Hentsch 55 Amtech commented 55 PS# [001] 55 Craig Tuttle Transgenomic 55 pharmacokinetic PK study 55 Anthony J. Armini 55 Dr. Ihor Gussak 55 Pevion 55 Geoffrey Rotstein 55 pradefovir 55 Rik J Deitsch 55 Hedgehog antagonist 55 Catalyst Biosciences 55 Dr. Von Hoff 55 IsoTis OrthoBiologics 55 Nicholas Borys 55 Bioheart Inc. 55 AVAX 55 trastuzumab DM1 T DM1 55 Paradigm Spine 55 ELACYT 55 Inflazyme 55 JAK1 55 Kjetil Hestdal 55 Gentium 55 Applied NeuroSolutions 55 Pepscan 55 Genfit 55 Miguel Cardozo 55 DiscoveryBioMed 55 PDE4 inhibitor 55 Ryuji Ueno 55 HCV Protease Inhibitor 55 Solasia 55 A3 adenosine receptor 55 Panzem R NCD 55 Tarek Sherif 55 Ms. Katen 54 Inergetics 54 Transave 54 H. Willard Flamel 54 Exherin TM 54 Cerimon 54 Senetek PLC 54 Stephen M. Simes 54 GRAVITAS trial 54 alvimopan 54 Presents Preclinical Data 54 Ketotransdel 54 ACCLAIM II 54 David Crockford RegeneRx 54 Thiovir 54 Dr. Axel Herberg 54 Friedhelm Blobel 54 Jens Schneider Mergener 54 NVA# 54 SonoLysis 54 Vaccinex 54 Luniel de Beer 54 Robert D. Battis 54 defensin mimetic antibiotic 54 CEO WH Marmion 54 tezampanel NGX# 54 CCX# B 54 Martin Nicklasson CEO 54 inhibit metastasis 54 Paul Cofoni CACI 54 Egrifta 54 Orqis Medical 54 eTag assays 54 Yuichi Iwaki MD Ph.D. 54 Liprotamase 54 favorable pharmacokinetic profile 54 eniluracil 54 Dr. Halvor Jaeger 54 Cardioxyl 54 Circ Pharma 54 Chas Radovich 54 Willi Food commented 54 Endotis 54 Catena ® 54 Auxilium Pharma 54 Hematide ™ 54 XmAb# 54 Anavex #-# 54 Paul Bisaro Watson 54 Phenomix Corporation 54 Flutiform TM 54 CEO Jai Nagarkatti 54 Boyd Soussana 54 INCB# [001] 54 Biolipox 54 VisEn Medical 54 ViroStatics 54 phase IIb clinical 54 registrational trial 54 Demopulos 54 Girindus 54 Dr. Anil Diwan 54 Nick Leschly 54 Michael Fonstein Ph.D. 54 EMPOWER ™ 54 CEO Nadav Kidron 54 Wellstat 54 EchoCRT 54 Canasia stated 54 mtm laboratories 54 Dr. Boro Dropulic 54 APTIMA HPV assay 54 Haim Aviv 54 Helix BioPharma 54 KineMed 54 Mersana 54 EP #R 54 Malcolm Skolnick CytoGenix 54 Gerd Zettlmeissl 54 Peter Tagliamonte President 54 Therion Biologics Corporation 54 Logical Therapeutics 54 TBC# 54 plasma kallikrein inhibitor 54 phase IIa 54 Glenn A. Oclassen 54 VIRxSYS 54 IIa trial 54 JJ Finkelstein 54 GENFIT 54 Ampio 54 Clinuvel 54 cariprazine 54 Aplidin 54 InfaCare 54 IntegraGen 54 Richard Treagus 54 Graeme Sewell 54 Harold H. Shlevin 54 p# inhibitor 54 rhFVIIa 54 Cenix 54 Sean Roosen President 54 Mark Hilz President 54 Fereydoun Firouz 54 Richmond McKinnish Carlisle 54 PROMACTA 54 SALVAT 54 eltrombopag 54 Exploration Orbite 54 JJ Finkelstein RegeneRx 54 Keryx Biopharmaceuticals 54 Richard Warke 54 GSK# [002] 54 Dr. Ferenc Darvas 54 Jean Pierre Sommadossi 54 Ron Bentsur Chief Executive 54 oral taxane 54 Jean Francois Rossignol 54 John Castiglione ubroadcast 54 Raymond P. Warrell 54 Fibrocell Science 54 heterozygous FH 54 Abiraterone acetate 54 DeveloGen 54 Visit www.BASInc.com 54 Peer Schatz QIAGEN 54 Raghu Kilambi 54 TOPICA 54 Medifacts 54 BrachySil TM 54 Zerenex 54 pitavastatin 54 NovImmune 54 Presents Preclinical 54 Doug Neugold ATMI 54 Luc Tanguay 54 MEK inhibitors 54 Zeb Horowitz 54 Celator 54 ruxolitinib 54 BioGeneriX 54 Luveniq 54 Idera Pharmaceuticals 54 SinuNase 54 Bioral Amphotericin B 54 Initiates Clinical Trial 54 TSX VENTURE URO 54 Jean François Mouney 54 Therabel 54 Ron Najafi 54 Alexei Marko 54 Shire HGT 54 Zafgen 54 Welichem 54 Dr. Dreismann 54 Virulizin R 54 zileuton IV 54 M. Capek Ph.D. 54 Myrexis Inc. 54 Homi Shamir 54 THALOMID 54 GENR 54 ProNAi 54 Francis DiNuzzo 54 CA9 SCAN 54 Lyle Jensen GreenMan 54 ESBATech AG 54 Tom Drivas President 54 Simon Moroney 54 BioInvent commented 54 Sayan Navaratnam 54 crofelemer 54 Alan Kingsman 54 John McDermott Endologix 54 VerifyNow System 53 Farhad Abasov Allana 53 AERx iDMS 53 Robin Stracey 53 NasdaqGM NTEC today 53 Gearóid Faherty Chairman 53 Anti Infective 53 InNexus Biotechnology 53 Armen PhD 53 Diamyd ® 53 Gearoid Faherty Chairman 53 GATTEX TM 53 Plicera 53 Diasome 53 Dr. Joachim Kreuzburg 53 Karo Bio 53 enGene 53 Dr. Weidong Yin 53 Lars Rebien Sorensen 53 Ronald Brus Crucell 53 Miravant 53 Unither Pharmaceuticals 53 PRESEPT Study 53 OTCBB HXBM developer 53 Vincent Renz NewCardio 53 TapImmune 53 Tomas Leanderson 53 Richard Garr Neuralstem 53 PEG SN# 53 OGeS 53 Kauffman MD Ph.D. 53 Joost Holthuis 53 Reverset 53 Svein Lien 53 Lantibio 53 ClinTec International 53 Tomas Puusepp 53 OvaRex R 53 TSX VENTURE ABI 53 Richard J. Meelia 53 William J. Gastle 53 Jeff Morhet 53 Garth Likes 53 NASDAQ DYAX 53 Guanilib 53 NV1FGF 53 Etubics 53 Haro Hartounian 53 Velac 53 Levitt MD Ph.D. 53 Dr. Sijmen de 53 Mr. Zhenjiang Yue 53 ApoB SNALP 53 Evoltra TM 53 Alfacell 53 Bud Brigham 53 Cylene 53 VALSTAR 53 Steven Ratoff 53 lixivaptan 53 Dr. AF Zerrouk 53 John Carlesso 53 tranilast 53 anidulafungin 53 Ostarine ™ 53 Stragen 53 Tobira Therapeutics Inc. 53 CytoFabTM 53 PRESEPT 53 Quark Biotech Inc. 53 WILEX AG 53 Phase Ib II 53 Radu Leca 53 ImmunoVEX HSV2 53 Relypsa 53 ALS #-# 53 Successfully Completes Phase 53 OTCBB IMUC 53 Igor Gonda Ph.D. 53 Ms. Lurker 53 George W. LeMaitre 53 Resverlogix 53 PAION 53 AVXL 53 Neuraltus 53 Polymeropoulos 53 Bezielle 53 BioSeek 53 Paolo Pucci 53 thetreatment 53 David Spaight 53 Zyngenia 53 Altastaph 53 Dr. Gamzu 53 Protalex 53 SEQUENOM 53 PSN# [002] 53 Nasdaq ANDS 53 Mr. Xu Kecheng 53 Phase #b/#a 53 ANAVEX #-# [003] 53 Eamonn Hobbs 53 Chronogen 53 Oglemilast 53 GALNS 53 Gerald Panneton President 53 Urocortin 2 53 Don Kiepert President 53 RSC FRANKFURT RF9 53 Dr. Chaumillon 53 Kenneth I. Moch 53 rALLy trial 53 OMRIX 53 Cohen OPNET 53 SwissINSO 53 CONBRIZA 53 Dyloject TM 53 OvaRex 53 Staph Leavenworth Bakali 53 Mr. Yves Marmet 53 Stephen Ghiglieri 53 Syntonix 53 AMEX REX 53 L. Berns 53 Jeffrey Buchalter 53 immunosuppressant therapies 53 Anturol TM 53 Elixir Pharmaceuticals 53 rasagiline tablets 53 Advitech 53 Panzem 53 InVasc 53 AngioChem 53 Eric Krasnoff Pall 53 FACTIVE tablets 53 GGF2 53 velafermin 53 Jean Gabriel Pérès 53 Oramed 53 Blane Walter 53 Pierre Cassigneul 53 ARIKACE ™ 53 Founding Scientist 53 Klaus Schollmeier 53 Nanobody 53 Walter Witoshkin 53 SWX SPPN 53 Technosphere Insulin